Paper42495331
Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications.
Belete M and 2 others. ACS Omega, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications. Papers, record 42495331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42495331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Advances in Pyrimidine Molecular Hybrids, Green Synthetic Strategies, and Diverse Biological Applications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38856835 | Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review. | Mol Divers | 2025 | https://conductscience.org/library/papers/38856835 | PubMed |
| 2 | 35755264 | Novel Pyrimidine Derivatives Bearing a 1,3,4-Thiadiazole Skeleton: Design, Synthesis, and Antifungal Activity. | Front Chem | 2022 | https://conductscience.org/library/papers/35755264 | PubMed |
| 3 | 19670193 | The three-component biginelli reaction: a combined experimental and theoretical mechanistic investigation. | Chemistry | 2009 | https://conductscience.org/library/papers/19670193 | PubMed |
| 4 | 39834253 | Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities. | Arch Pharm (Weinheim) | 2025 | https://conductscience.org/library/papers/39834253 | PubMed |
| 5 | 25383216 | Significance and biological importance of pyrimidine in the microbial world. | Int J Med Chem | 2014 | https://conductscience.org/library/papers/25383216 | PubMed |
| 6 | 31517529 | Recent advances of thiazole hybrids in biological applications. | Future Med Chem | 2019 | https://conductscience.org/library/papers/31517529 | PubMed |
| 7 | 39133616 | Antioxidant and Antimicrobial Activities of 4H-Chromene Based Indole-Pyrimidine Hybrids: Synthesis and Molecular Docking Studies. | Chem Biodivers | 2024 | https://conductscience.org/library/papers/39133616 | PubMed |
| 8 | 41602180 | Thienopyrimidine scaffolds as promising antimicrobial agents: synthesis, biological evaluation, DFT analysis and molecular docking. | RSC Adv | 2026 | https://conductscience.org/library/papers/41602180 | PubMed |
| 9 | 41815403 | Regioselective synthesis, structural investigation and binding behavior of 6-aroyl-7-aryl-5-methyl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidines with BSA using various spectroscopic and in silico methods. | RSC Adv | 2026 | https://conductscience.org/library/papers/41815403 | PubMed |
| 10 | 39691514 | Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided Hybridization. | ACS Med Chem Lett | 2024 | https://conductscience.org/library/papers/39691514 | PubMed |
| 11 | 38837417 | Unlocking nitrogen compounds' promise against malaria: A comprehensive review. | Arch Pharm (Weinheim) | 2024 | https://conductscience.org/library/papers/38837417 | PubMed |
| 12 | 39456793 | Pyrimidine Derivatives as Selective COX-2 Inhibitors with Anti-Inflammatory and Antioxidant Properties. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39456793 | PubMed |
| 13 | 37197676 | Antioxidant activity of novel nitrogen scaffold with docking investigation and correlation of DFT stimulation. | RSC Adv | 2023 | https://conductscience.org/library/papers/37197676 | PubMed |
| 14 | 40504040 | Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives. | ChemMedChem | 2025 | https://conductscience.org/library/papers/40504040 | PubMed |
| 15 | 41531954 | Radiosynthesis and Preclinical Evaluation of a Novel 11C‑Labeled Pyrazolopyrimidine Derivative for Positron Emission Tomography Imaging of Phosphodiesterase 2A. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/41531954 | PubMed |
| 16 | 32797654 | Recent Development of Pyrimidine-Containing Antimicrobial Agents. | ChemMedChem | 2020 | https://conductscience.org/library/papers/32797654 | PubMed |
| 17 | 40656568 | De novo drug design and biological evaluation of coumarin-pyrimidine co-drug derivatives as diabetic inhibitors: expanding a multi-algorithm approach with the integration of machine learning in pharmaceutical research. | RSC Adv | 2025 | https://conductscience.org/library/papers/40656568 | PubMed |
| 18 | 41519811 | Synthesis and antitumor property of triazole-aryloxyacetyl hydrazide hybrids with furo[2,3-d]pyrimidine scaffold. | BMC Chem | 2026 | https://conductscience.org/library/papers/41519811 | PubMed |
| 19 | 41900130 | Nanoparticle-Catalysed Microwave-Driven MCRs for Sustainable Heterocycle Synthesis. | Molecules | 2026 | https://conductscience.org/library/papers/41900130 | PubMed |
| 20 | 41381722 | Synthesis, molecular docking, ADMET studies and biological evaluation of fused pyrazolopyridopyrimidine derivatives as antioxidant and antimicrobial agents. | Sci Rep | 2025 | https://conductscience.org/library/papers/41381722 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42943798 | Coumarin-Ferulic Acid Hybrid Mediates HT-29-Selective Growth Inhibition and Proteomic Profiling. | Molecules | 2026 | https://conductscience.org/library/papers/42943798 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MT-CO2 | 4513 | PubTator's text mining | https://conductscience.org/library/genes/4513 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42495331
GET https://conductscience.org/api/papers/v1/42495331/references?page=2